内皮细胞的免疫调节:癌症治疗的前景
Halima Alnaqbi1, Lisa M Becker2, Mira Mousa3
1Center for Biotechnology, Khalifa University, Abu Dhabi, United Arab Emirates; Department of Biomedical Engineering and Biotechnology, Khalifa University, Abu Dhabi, United Arab Emirates.
Trends in cancer
|September 17, 2024
概括
免疫调节性内皮细胞 (IMECs) 是瘤微环境中的关键参与者,影响癌症生长和免疫逃避. 针对IMEC提供了增强癌症免疫疗法的有希望的策略.
科学领域:
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 瘤微环境研究 研究
背景情况:
- 瘤内皮细胞 (TEC) 是瘤微环境 (TME) 的关键组成部分,支持瘤进展和免疫逃避.
- 免疫调节性内皮细胞 (IMEC) 是一种塑料内皮细胞 (EC) 现型,在各种条件下具有显著的免疫调节能力.
研究的目的:
- 在癌症生物学中审查和综合有关IMEC的当前知识.
- 使用单细胞数据,在不同瘤类型,疾病和物种中比较IMEC特征和功能动态.
- 探索针对IMEC的治疗潜力,以优化癌症治疗和免疫疗法.
主要方法:
- 综合文献综述,重点关注单细胞报告和关于IMECs在癌症中的研究.
- 在各种癌症模型中对IMEC表型,功能和动态进行比较分析.
- 研究IMEC与免疫系统的相互作用及其对治疗疗效的影响.
主要成果:
- TECs,特别是IMECs,在促进瘤生长和促进TME内的免疫逃避方面发挥着重要作用.
- 单细胞分析揭示了IMEC在各种癌症类型和疾病中的不同特征和动态功能.
- IMECs影响现有癌症疗法的疗效,并为新型免疫治疗策略提供潜在的目标.
结论:
- 了解IMEC在癌症中的多方面的作用对于开发有效的治疗策略至关重要.
- 利用IMEC作为治疗点对提高癌症免疫疗法的疗效具有重大前景.
- 对IMEC生物学进行进一步的研究是有必要的,以充分利用其在瘤学中的潜力.
相关概念视频
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


